Logo image of YAAS

YOUXIN TECHNOLOGY LTD-CL A (YAAS) Stock Fundamental Analysis

NASDAQ:YAAS - Nasdaq - KYG9876W1042 - Common Stock - Currency: USD

3.7088  -1.1 (-22.89%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to YAAS. YAAS was compared to 82 industry peers in the IT Services industry. Both the profitability and financial health of YAAS have multiple concerns. YAAS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year YAAS has reported negative net income.
YAAS had a negative operating cash flow in the past year.
YAAS Yearly Net Income VS EBIT VS OCF VS FCFYAAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M

1.2 Ratios

The Return On Assets of YAAS (-133.67%) is worse than 95.12% of its industry peers.
Industry RankSector Rank
ROA -133.67%
ROE N/A
ROIC N/A
ROA(3y)-209.8%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
YAAS Yearly ROA, ROE, ROICYAAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

Looking at the Gross Margin, with a value of 65.54%, YAAS belongs to the top of the industry, outperforming 82.93% of the companies in the same industry.
YAAS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
YAAS Yearly Profit, Operating, Gross MarginsYAAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -200 -400

More info and screens

0

2. Health

2.1 Basic Checks

YAAS does not have a ROIC to compare to the WACC, probably because it is not profitable.
YAAS has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, YAAS has a worse debt to assets ratio.
YAAS Yearly Shares OutstandingYAAS Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
YAAS Yearly Total Debt VS Total AssetsYAAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M

2.2 Solvency

YAAS has an Altman-Z score of -4.47. This is a bad value and indicates that YAAS is not financially healthy and even has some risk of bankruptcy.
YAAS has a Altman-Z score of -4.47. This is amonst the worse of the industry: YAAS underperforms 91.46% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.47
ROIC/WACCN/A
WACC7.82%
YAAS Yearly LT Debt VS Equity VS FCFYAAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -2M -4M

2.3 Liquidity

A Current Ratio of 0.10 indicates that YAAS may have some problems paying its short term obligations.
The Current ratio of YAAS (0.10) is worse than 97.56% of its industry peers.
A Quick Ratio of 0.10 indicates that YAAS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.10, YAAS is doing worse than 97.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
YAAS Yearly Current Assets VS Current LiabilitesYAAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48.62% over the past year.
Looking at the last year, YAAS shows a very negative growth in Revenue. The Revenue has decreased by -41.83% in the last year.
EPS 1Y (TTM)48.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.62%
Revenue 1Y (TTM)-41.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.83%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
YAAS Yearly Revenue VS EstimatesYAAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 200K 400K 600K 800K 1M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

YAAS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
YAAS Price Earnings VS Forward Price EarningsYAAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
YAAS Per share dataYAAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for YAAS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

YOUXIN TECHNOLOGY LTD-CL A

NASDAQ:YAAS (6/26/2025, 3:41:03 PM)

3.7088

-1.1 (-22.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.05%
Inst Owner ChangeN/A
Ins Owners16.03%
Ins Owner ChangeN/A
Market Cap124.43M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 238.74
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.02
BVpS-0.08
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -133.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.54%
FCFM N/A
ROA(3y)-209.8%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z -4.47
F-Score4
WACC7.82%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y68.48%
OCF growth 3YN/A
OCF growth 5YN/A